Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,096 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $486.23 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $162.48 | 6 | $0 (2022) |
| Lilly USA, LLC | $69.25 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $65.31 | 4 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $48.73 | 3 | $0 (2017) |
| PFIZER INC. | $38.10 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $37.19 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $27.36 | 2 | $0 (2019) |
| DEXCOM, INC. | $24.96 | 1 | $0 (2021) |
| Abbott Laboratories | $23.42 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $110.86 | 5 | Lilly USA, LLC ($49.78) |
| 2023 | $149.04 | 7 | Novo Nordisk Inc ($90.47) |
| 2022 | $327.91 | 13 | Novo Nordisk Inc ($203.98) |
| 2021 | $170.25 | 4 | Novo Nordisk Inc ($130.55) |
| 2020 | $164.55 | 5 | AstraZeneca Pharmaceuticals LP ($120.13) |
| 2019 | $27.36 | 2 | E.R. Squibb & Sons, L.L.C. ($27.36) |
| 2018 | $43.96 | 3 | Supernus Pharmaceuticals, Inc. ($15.62) |
| 2017 | $101.78 | 7 | SANOFI-AVENTIS U.S. LLC ($48.73) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Diabetes Care | ||||||
| 08/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.92 | General |
| 05/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Obesity | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Diabetes | ||||||
| 09/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Diabetes | ||||||
| 09/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Diabetes | ||||||
| 06/30/2023 | C2Dx, Inc | — | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| 03/21/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Diabetes | ||||||
| 02/21/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Diabetes | ||||||
| 02/06/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Diabetes | ||||||
| 11/23/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.82 | General |
| 09/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2022 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: EndoVenous Therapies | ||||||
| 07/25/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Neuroscience | ||||||
| 07/21/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.54 | General |
| 06/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Diabetes | ||||||
| 06/11/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: VACCINES | ||||||
| 06/09/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $103.23 | General |
| Category: Diabetes | ||||||
| 05/26/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/18/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: VACCINES | ||||||
| 04/02/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/18/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,124 | 1,524 | $314,629 | $121,419 |
| 2022 | 19 | 1,309 | 1,743 | $345,261 | $148,773 |
| 2021 | 18 | 1,204 | 1,605 | $280,512 | $123,242 |
| 2020 | 18 | 1,273 | 1,597 | $252,612 | $111,217 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 251 | 545 | $141,155 | $48,190 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 189 | 189 | $59,724 | $25,207 | 42.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 97 | $35,502 | $13,042 | 36.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $9,875 | $7,038 | 71.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 84 | 87 | $9,443 | $6,238 | 66.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 67 | $11,926 | $4,338 | 36.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 43 | 43 | $7,869 | $3,289 | 41.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 88 | 91 | $4,818 | $2,917 | 60.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $8,532 | $2,902 | 34.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 15 | $7,230 | $2,529 | 35.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 153 | 211 | $4,642 | $1,756 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,872 | $1,318 | 34.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 27 | $4,536 | $1,164 | 25.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $1,419 | $961.50 | 67.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 25 | $2,050 | $257.86 | 12.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 25 | $1,700 | $238.00 | 14.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 16 | $336.00 | $35.20 | 10.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 252 | 592 | $139,120 | $52,954 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 188 | 188 | $59,408 | $25,725 | 43.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 86 | 109 | $36,188 | $16,238 | 44.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 159 | 159 | $29,097 | $12,959 | 44.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 104 | 107 | $7,811 | $7,249 | 92.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 102 | $16,422 | $5,975 | 36.4% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 17 | 17 | $5,406 | $4,018 | 74.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $4,844 | $3,626 | 74.9% |
About Dr. Archana Goel, MD
Dr. Archana Goel, MD is a Internal Medicine healthcare provider based in Elgin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063529832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Archana Goel, MD has received a total of $1,096 in payments from pharmaceutical and medical device companies, with $110.86 received in 2024. These payments were reported across 46 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,096).
As a Medicare-enrolled provider, Goel has provided services to 4,910 Medicare beneficiaries, totaling 6,469 services with total Medicare billing of $504,652. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Elgin, IL
- Active Since 08/25/2006
- Last Updated 06/16/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1063529832
Products in Payments
- Ozempic (Drug) $249.31
- FARXIGA (Drug) $149.33
- RYBELSUS (Drug) $112.85
- MOUNJARO (Drug) $69.25
- ELIQUIS (Drug) $49.79
- XARELTO (Drug) $46.88
- TOUJEO (Drug) $30.78
- DEXCOM G6 TRANSMITTER (Device) $24.96
- BEXSERO (Biological) $23.52
- FREESTYLE LIBRE 3 (Device) $23.42
- Wegovy (Drug) $22.74
- BOTOX (Biological) $22.73
- Rybelsus (Drug) $22.48
- SPIRIVA RESPIMAT (Drug) $18.97
- SPRAVATO (Drug) $18.43
- SOLIQUA (Drug) $17.95
- PREVNAR 20 (Biological) $15.67
- TROKENDI XR (Drug) $15.62
- JANUVIA (Drug) $14.67
- ADVAIR (Drug) $13.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elgin
Mr. Michael Hernandez, M.d, M.D
Internal Medicine — Payments: $26,674
Dr. Robert Tiballi, D.o, D.O
Internal Medicine — Payments: $20,485
Paula Belmar, Md, MD
Internal Medicine — Payments: $12,301
Dr. Heena Shyamani, M.d, M.D
Internal Medicine — Payments: $12,014
Mr. Richard Baley, M.d, M.D
Internal Medicine — Payments: $11,178
John Adams, Md, MD
Internal Medicine — Payments: $10,883